Manufacturer restrictions and 340B Validate
Support better patient outcomes and reduce the chance of manufacturer audits
Born out of recent changes in the industry, the rise of duplicate discounts has led several manufacturers to restrict access to 340B pricing. 340B Validate is a win-win for both covered entities and manufacturers.
Current customer? Client login
Optimize your program participation
Manage your 340B rebate compliance with minimal impact
340B Validate provides manufacturers with validation of your 340B prescriptions that generate a rebate request—without revealing your identity or data as a covered entity. The fast-changing 340B drug pricing ecosystem calls for Macro Helix’s reliable solutions to help you engage in the program easily and assist with meeting compliance needs as they arise—so your patients can continue to experience the benefits of 340B.
Who should use 340B Validate and manufacturer solutions?
Manufacturers
Pharmaceutical companies that manufacture and distribute 340B-eligible products.
Contract Pharmacies
These pharmacies enter into an agreement with a covered entity to provide services to the covered entity's patients, including dispensing entity-owned 340B drugs.
Health Systems
According to federal guidelines published by the Health Resources and Services Administration, a hospital that is private and non-profit with a contract with a state or local government to provide health care services to low-income individuals who are not entitled to benefits under Medicare or eligible for State Medicaid, is eligible for the 340B Drug Pricing Program.
Solutions you can start using today if you have 340B Architect
Price-based automatic 340B exclusion and DoNotOrder list
We will analyze NDC pricing updates from your primary wholesaler and if we detect that you may have lost contract pricing, we will place the affected NDCs on either your 340B Exclusion list, DoNotOrder(340B) list, or both, based on your settings.
Managing "Manufacturer 45-Day Lookback" requirements
We implemented logic to help our customers maintain an accumulations balance that accounts for a manufacturer's timeliness policies. We continue to update and work through compliance and product requirements to facilitate this feature of our software by soliciting customer feedback about their experiences submitting to manufacturers.
A bridge between manufacturers and covered entities
Macro Helix is at the intersection of proven pharmacy practices and modern methods of running a patient-centered business. We navigate many regulatory and compliance rules associated with 340B programs, making it easier for covered entities to meet patient needs and remain successful. As part of McKesson, we can help you explore additional solutions across our lines of business to further support your pharmacy operations. We also work seamlessly with all 340B entities that utilize any of the national pharmaceutical distributors.
Answers to your questions about 340B Validate
Manufacturer Restrictions FAQs
The One McKesson Value
A partner you can rely on for end-to-end solutions
Our team of pharmacy operations and implementation specialists brings real-world experience and subject-matter expertise to every one of our clients. Macro Helix innovation is inspired by nearly 200 years of McKesson healthcare leadership and perspective. Learn more about different solutions across our businesses that can help you achieve your goals, such as advancing health outcomes in your community.
Patient receives a prescription to take home from doctor at an eligible hospital or clinic
Patient collects medication at the pharmacy and pays copay
Hospital contracts with a pharmacy via Macro Helix Advanced 340B Technology Suite
Pharmacy bills insurance for the medication’s full value and dispensing fee
The hospital buys the medication at a discount direct from the manufacturer using Macro Helix Advanced 340B Technology Suite
General News
Complete Compliance
May 4, 2022
Addressing the complexities and frustrations around 340B compliance with software management solutions for 340B programs.
Is Contrast Media An Outpatient Drug?
May 3, 2022
Tips for covered entities that choose to include radiology products in their 340B program.
Celebrating Our Women in Tech: Catherine Woodling
May 2, 2022
Meet Catherine Woodling, a senior project manager who finds in Macro Helix a perfect place to combine her twin interests in technology and healthcare.